Clonazepam Should Not Be Used as Primary Treatment for Bipolar Disorder
Clonazepam is not a first-line or primary treatment for bipolar disorder and should only be used as an adjunctive agent for acute agitation and sleep disturbance in mania, not as a mood stabilizer. The FDA has approved clonazepam only for seizure disorders and panic disorder—not for bipolar disorder 1.
Primary Treatment Recommendations
According to established guidelines, pharmacotherapy for bipolar disorder should begin with FDA-approved mood stabilizers or atypical antipsychotics 2:
First-Line Agents:
- Lithium (approved down to age 12 for acute mania and maintenance)
- Valproate
- Atypical antipsychotics: aripiprazole, olanzapine, risperidone, quetiapine, ziprasidone
- Lamotrigine (for maintenance and bipolar depression)
Limited Role of Clonazepam
The guidelines explicitly state that benzodiazepines like clonazepam are used in adult studies to stabilize acute agitation and sleep disturbance associated with mania but may cause disinhibition in younger children 2. This is a critical distinction—clonazepam addresses symptoms, not the underlying mood disorder.
Key Evidence Limitations:
While some older research from the 1980s-1990s suggested clonazepam might have antimanic properties 3, 4, 5, 6, these studies had significant limitations:
- Very small sample sizes (often <20 patients)
- Primarily used as adjunctive therapy, not monotherapy
- No large-scale, modern randomized controlled trials
More concerning, a 2010 STEP-BD study found that benzodiazepine use was associated with a 21% increased risk of mood episode recurrence (HR 1.21,95% CI 1.01-1.45) 7. This suggests benzodiazepines may actually worsen long-term outcomes in bipolar disorder.
Clinical Algorithm
For acute mania:
- Start lithium, valproate, or an atypical antipsychotic
- If severe agitation/insomnia is present, add clonazepam temporarily (days to weeks)
- Taper clonazepam once acute symptoms stabilize
- Continue primary mood stabilizer long-term
For maintenance treatment:
- Use lithium, lamotrigine, or olanzapine
- Avoid chronic benzodiazepine use due to dependence risk and potential for increased recurrence 7
Critical Pitfalls to Avoid
- Never use clonazepam as monotherapy for bipolar disorder—it does not prevent mood episodes
- Avoid long-term benzodiazepine use in bipolar patients due to dependence, tolerance, and possible increased recurrence risk
- Watch for disinhibition in younger patients, which can worsen manic symptoms 2
- Do not confuse symptom relief with disease modification—controlling agitation is not the same as treating bipolar disorder
The evidence is clear: clonazepam has a narrow, time-limited role as an adjunct for acute symptoms only, while FDA-approved mood stabilizers and antipsychotics remain the cornerstone of bipolar disorder treatment 2.